SurModics Inc (SRDX) - Total Liabilities
Based on the latest financial reports, SurModics Inc (SRDX) has total liabilities worth $58.51 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SurModics Inc - Total Liabilities Trend (1998–2024)
This chart illustrates how SurModics Inc's total liabilities have evolved over time, based on quarterly financial data. See SRDX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
SurModics Inc Competitors by Total Liabilities
The table below lists competitors of SurModics Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
USA | $27.11 Million |
|
Surya Roshni Limited
NSE:SURYAROSNI
|
India | Rs9.40 Billion |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273
|
China | CN¥158.97 Million |
|
Fuan Pharmaceutical Group Co
SHE:300194
|
China | CN¥1.51 Billion |
|
Suzhou Alton Electrical & Mechanical Industry Co. Ltd.
SHE:301187
|
China | CN¥2.75 Billion |
|
MarineMax Inc
NYSE:HZO
|
USA | $1.48 Billion |
|
NorthIsle Copper and Gold Inc
V:NCX
|
Canada | CA$5.30 Million |
|
Castle Biosciences Inc
NASDAQ:CSTL
|
USA | $86.39 Million |
Liability Composition Analysis (1998–2024)
This chart breaks down SurModics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SurModics Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SurModics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SurModics Inc (1998–2024)
The table below shows the annual total liabilities of SurModics Inc from 1998 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-09-30 | $59.66 Million | -9.36% |
| 2023-09-30 | $65.82 Million | +31.73% |
| 2022-09-30 | $49.97 Million | -8.33% |
| 2021-09-30 | $54.51 Million | +44.55% |
| 2020-09-30 | $37.71 Million | +0.96% |
| 2019-09-30 | $37.35 Million | -32.73% |
| 2018-09-30 | $55.52 Million | +121.78% |
| 2017-09-30 | $25.04 Million | -3.93% |
| 2016-09-30 | $26.06 Million | +281.18% |
| 2015-09-30 | $6.84 Million | +11.39% |
| 2014-09-30 | $6.14 Million | -24.28% |
| 2013-09-30 | $8.11 Million | -11.65% |
| 2012-09-30 | $9.18 Million | -47.02% |
| 2011-09-30 | $17.32 Million | +8.78% |
| 2010-09-30 | $15.92 Million | +20.70% |
| 2009-09-30 | $13.19 Million | -73.20% |
| 2008-09-30 | $49.22 Million | +21.81% |
| 2007-09-30 | $40.41 Million | +231.25% |
| 2006-09-30 | $12.20 Million | +41.13% |
| 2005-09-30 | $8.64 Million | -43.42% |
| 2004-09-30 | $15.28 Million | +30.64% |
| 2003-09-30 | $11.69 Million | +61.23% |
| 2002-09-30 | $7.25 Million | +48.54% |
| 2001-09-30 | $4.88 Million | +99.63% |
| 2000-09-30 | $2.45 Million | +6.35% |
| 1999-09-30 | $2.30 Million | +43.75% |
| 1998-09-30 | $1.60 Million | -- |
About SurModics Inc
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision o… Read more